Jump to content

Sarcoglycan

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 131.94.186.30 (talk) at 01:23, 12 February 2011. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Template:FixBunching

Sarcoglycan beta/gamma/delta
Identifiers
SymbolSarcoglycan_1
PfamPF04790
InterProIPR006875
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary

Template:FixBunching

Sarcoglycan alpha/epsilon
Identifiers
SymbolSarcoglycan_2
PfamPF05510
InterProIPR008908
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary

Template:FixBunching The sarcoglycans are a family of transmembrane proteins[1] (α, β, γ, δ or ε) involved in the protein complex responsible for connecting the muscle fibre cytoskeleton to the extracellular matrix, preventing damage to the muscle fibre sarcolemma through shearing forces.

The dystrophin glycoprotein complex (DGC) is a membrane-spanning complex that links the interior cytoskeleton to the extracellular matrix in muscle. The sarcoglycan complex is a subcomplex within the DGC and is composed of several muscle-specific, transmembrane proteins (alpha-, beta-, gamma-, delta- and zeta-sarcoglycan). The sarcoglycans are asparagine-linked glycosylated proteins with single transmembrane domains.[2][3]

The disorders caused by the mutations of the sarcoglycans are called sarcoglycanopathies. Mutations in the α, β, γ or δ genes (not ε) encoding these proteins can lead to the associated limb-girdle muscular dystrophy.

Genes

References

  1. ^ Sarcoglycans at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
  2. ^ Zheng Y, Chockalingam PS, Cholera R, Oak SA, Jarrett HW, Thomason DB (2002). "Dystrophin-glycoprotein complex and Ras and Rho GTPase signaling are altered in muscle atrophy". Am J Physiol Cell Physiol. 283 (2): -. doi:10.1152/ajpcell.00529.2001. PMID 12107060.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^ Wheeler MT, Zarnegar S, Mcnally EM (2002). "zeta-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy". Hum. Mol. Genet. 11 (18): 2147–2154. doi:10.1093/hmg/11.18.2147. PMID 12189167.{{cite journal}}: CS1 maint: multiple names: authors list (link)
This article incorporates text from the public domain Pfam and InterPro: IPR006875